Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Progenitor Cell Mobilisation

Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?

Summary:

About 10–30% of patients with non-Hodgkin's lymphoma (NHL) intended to receive high-dose therapy are difficult to mobilise. Damage to the stem cell pool caused by previous chemotherapy may be an important factor in predicting progenitor cell mobilisation. We have analysed associations between chemotherapy score and efficiency of progenitor cell mobilisation in 120 consecutive NHL patients mobilised with intermediate-dose cyclophosphamide (4 g/m2) plus G-CSF. The original chemotherapy scoring system proposed by Drake et al was applicable in only 27% of our patients and was not predictive for mobilisation outcome. Therefore we made an improved scoring system for previous chemotherapy by adding new drugs. Altogether, 111 patients (93%) could be scored. Our chemotherapy score showed an inverse correlation with the peak blood CD34+ count measured after the mobilisation (r=−0.214, P=0.024) and with the number of CD34+ cells collected (r=−0.234, P=0.02). However, in the receiver operating characteristics curve, no threshold value could be detected for chemotherapy score predicting mobilisation failure. Thus, both the original scoring system as well as our more widely applicable scoring system seem to be of limited value in predicting progenitor cell mobilisation in patients with NHL.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Gratwohl A, Passweg J, Baldomero H et al. Hematopoietic stem cell transplant activity in Europe 1999. Bone Marrow Transplant 2001; 27: 899–916.

    Article  CAS  Google Scholar 

  2. Gratwohl A, Baldomero H, Horisberger B et al for The Accreditation Committee of The European Group for Blood and Marrow Transplantation (EBMT). Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100: 2374–2386.

    Article  CAS  Google Scholar 

  3. Haas R, Möhle R, Fruhauf S et al. Patient characteristics associated with successful mobilization and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787–3794.

    CAS  Google Scholar 

  4. Drake M, Ranaghan L, Morris TCM et al. Analysis of the effect of prior chemotherapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997; 98: 745–749.

    Article  CAS  Google Scholar 

  5. Clark RE, Brammer CG . Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system. Bone Marrow Transplant 1998; 22: 859–863.

    Article  CAS  Google Scholar 

  6. Harris NL, Jaffe ES, Stein H et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.

    CAS  Google Scholar 

  7. Reiter A, Schrappe M, Parwaresh R et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage – a report of the Berlin–Frankfurt–Munster Group. J Clin Oncol 1995; 13: 359–372.

    Article  CAS  Google Scholar 

  8. Khouri IF, Romaguera J, Kantarjian H et al. Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 1998; 16: 3803–3809.

    Article  CAS  Google Scholar 

  9. Aurlien E, Holte H, Pharo A et al. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplant 1998; 21: 873–878.

    Article  CAS  Google Scholar 

  10. McQuaker I, Haynes A, Stainer C et al. Mobilisation of peripheral blood stem cells with IVE and G-CSF improves CD34+ cell yields and engraftment in patients with non-Hodgkin's lymphomas and Hodgkin's disease. Bone Marrow Transplant 1999; 24: 715–722.

    Article  CAS  Google Scholar 

  11. Moskowitz CH, Bertino JR, Glassman JR et al. Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant–eligible patients with non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3776–3785.

    Article  CAS  Google Scholar 

  12. Dormer P, Sauer H, Shalhorn A, Willmanns W . Differential effect of high-dose methotrexate on erythropoiesis and granulocytopoiesis in humans. Cancer Res 1982; 42: 1604–1697.

    CAS  PubMed  Google Scholar 

  13. Guigon M, Izumi-Hisha H, Mary J-Y . Long-term effects of high-doses of cytosine arabinoside on pluripotents stem cells (CFU-S). Exp Hematol 1989; 17: 203–207.

    CAS  PubMed  Google Scholar 

  14. Laszlo D, Galieni P, Raspadori D et al. Fludarabine-containing regimens may adversely affect peripheral blood stem cell collection in low-grade lymphoma patients. Leuk Lymphoma 2000; 37: 157–161.

    Article  CAS  Google Scholar 

  15. Ketterer N, Salles G, Moullet I et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998; 103: 235–242.

    Article  CAS  Google Scholar 

  16. Koumakis G, Vassilomanolakis M, Hatzichristou H et al. Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single aphaeresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies. Bone Marrow Transplant 1996; 18: 1065–1072.

    CAS  Google Scholar 

  17. Morton J, Morton A, Bird R et al. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate-dose cyclophosphamide and G-CSF. Leukemia Res 1997; 21: 21–27.

    Article  CAS  Google Scholar 

  18. Vantelon JM, Koscielny S, Brault P et al. Scoring system for the prediction of successful blood stem cell (PBSC) collection in non-Hodgkin's lymphoma (NHL): application in clinical practice. Bone Marrow Transplant 2000; 25: 495–499.

    Article  CAS  Google Scholar 

  19. Neben S, Hemman S, Montgomery M et al. Haematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol 1993; 21: 156–162.

    CAS  Google Scholar 

  20. Gardner RV, Lerner C, Astle CM, Harrison DE . Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay. Cancer Chemother Pharmacol 1993; 32: 450–454.

    Article  CAS  Google Scholar 

  21. Roberts AW, DeLuca E, Begley CG et al. Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 1995; 13: 512–516.

    Article  CAS  Google Scholar 

  22. Kessinger A, Sharp JG . The whys and hows of hematopoietic progenitor stem cell mobilization. Bone Marrow Transplant 2003; 31: 319–329.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Jantunen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jantunen, E., Kuittinen, T. & Nousiainen, T. Is chemotherapy scoring useful to predict progenitor cell mobilisation in patients with non-Hodgkin's lymphoma?. Bone Marrow Transplant 32, 569–573 (2003). https://doi.org/10.1038/sj.bmt.1704184

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704184

Keywords

This article is cited by

Search

Quick links